F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy

Health Consultant November 09, 2023 0

Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.

from NYT > Health https://ift.tt/iYc1jw8
via IFTTT

No comments

Subscribe to: Post Comments ( Atom )